Zobrazeno 1 - 10
of 810
pro vyhledávání: '"Pseudotyping"'
Autor:
Ferrero S; Laboratory of Pharmaceutical Biotechnology, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina., Batto MV; Laboratory of Pharmaceutical Biotechnology, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina., Gatto MI; Laboratory of Pharmaceutical Biotechnology, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina., Dimase F; Hemotherapy Division, Hospital Militar Central 601 Cirujano Mayor Dr. Cosme Argerich, Buenos Aires, Argentina., Helguera G; Laboratory of Pharmaceutical Biotechnology, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina.
Publikováno v:
Current protocols [Curr Protoc] 2024 Oct; Vol. 4 (10), pp. e70025.
Autor:
Thimmiraju SR; Texas Children's Hospital Center for Vaccine Development, Houston, TX 77030, USA.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX 77030, USA., Villar MJ; Texas Children's Hospital Center for Vaccine Development, Houston, TX 77030, USA.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX 77030, USA., Kimata JT; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Strych U; Texas Children's Hospital Center for Vaccine Development, Houston, TX 77030, USA.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX 77030, USA., Bottazzi ME; Texas Children's Hospital Center for Vaccine Development, Houston, TX 77030, USA.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Hotez PJ; Texas Children's Hospital Center for Vaccine Development, Houston, TX 77030, USA.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA., Pollet J; Texas Children's Hospital Center for Vaccine Development, Houston, TX 77030, USA.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX 77030, USA.; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.
Publikováno v:
Viruses [Viruses] 2024 Sep 20; Vol. 16 (9). Date of Electronic Publication: 2024 Sep 20.
Autor:
DeBarros K; Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA 30310, USA., Khan M; Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA 30310, USA., Coleman M; Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA 30310, USA., Bond VC; Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA 30310, USA., Floyd V; Department of Community Health and Preventive Medicine, 720 Westview Dr. SW, Atlanta, GA 30310, USA., Gbodossou E; PROMETRA International, Dakar-Etoile BP 6134, Senegal., Diop A; Malango Traditional Healers Association, Fatick BP 1763, Senegal., Krumpe LRH; Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA., O'Keefe BR; Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA.; Natural Products Branch, Developmental Therapeutic Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD 21702, USA., Powell MD; Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA 30310, USA.
Publikováno v:
Viruses [Viruses] 2024 Sep 07; Vol. 16 (9). Date of Electronic Publication: 2024 Sep 07.
Autor:
Cantoni D; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Wilkie C; School of Mathematics & Statistics, University of Glasgow, Glasgow, United Kingdom., Bentley EM; Medicines and Healthcare Products Regulatory Agency, South Mimms, United Kingdom., Mayora-Neto M; Viral Pseudotype Unit, Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Chatham, United Kingdom., Wright E; Viral Pseudotype Unit, School of Life Sciences, University of Sussex, Brighton, United Kingdom., Scott S; Viral Pseudotype Unit, Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Chatham, United Kingdom., Ray S; School of Mathematics & Statistics, University of Glasgow, Glasgow, United Kingdom., Castillo-Olivares J; Laboratory of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge University, Cambridge, United Kingdom., Heeney JL; Laboratory of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge University, Cambridge, United Kingdom.; DIOSynVax, University of Cambridge, Cambridge, United Kingdom., Mattiuzzo G; Medicines and Healthcare Products Regulatory Agency, South Mimms, United Kingdom., Temperton NJ; Viral Pseudotype Unit, Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Chatham, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Sep 18; Vol. 14, pp. 1184362. Date of Electronic Publication: 2023 Sep 18 (Print Publication: 2023).
Autor:
Solomon M; Lady Davis Institute, Jewish General Hospital, McGill Centre for Viral Diseases, Montreal, QC, Canada.; Department of Medicine, McGill University, Montreal, QC, Canada., Liang C; Lady Davis Institute, Jewish General Hospital, McGill Centre for Viral Diseases, Montreal, QC, Canada. chen.liang@mcgill.ca.; Department of Medicine, McGill University, Montreal, QC, Canada. chen.liang@mcgill.ca.
Publikováno v:
Advances in experimental medicine and biology [Adv Exp Med Biol] 2023; Vol. 1407, pp. 61-84.
Autor:
Nie J; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China., Wu X; Cell Collection and Research Center, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China., Wang Y; Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. wangyc@nifdc.org.cn.; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Kunming, China. wangyc@nifdc.org.cn.
Publikováno v:
Advances in experimental medicine and biology [Adv Exp Med Biol] 2023; Vol. 1407, pp. 29-44.
Autor:
Cui Q; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China., Huang W; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China. huangweijin@nifdc.org.cn.
Publikováno v:
Advances in experimental medicine and biology [Adv Exp Med Biol] 2023; Vol. 1407, pp. 45-60.
Autor:
Wang Y; Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. wangyc@nifdc.org.cn.; Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Kunming, China. wangyc@nifdc.org.cn., Zhou Z; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China., Wu X; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China., Li T; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China., Wu J; Beijing Yunling Biotechnology Co., Ltd., Beijing, China., Cai M; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China., Nie J; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China., Wang W; Division of Monoclonal Antibody Products, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China., Cui Z; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China.
Publikováno v:
Advances in experimental medicine and biology [Adv Exp Med Biol] 2023; Vol. 1407, pp. 1-27.
Autor:
Yuan F; State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing, China., Zheng A; State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing, China. zhengaihua@ioz.ac.cn.
Publikováno v:
Advances in experimental medicine and biology [Adv Exp Med Biol] 2023; Vol. 1407, pp. 329-348.
Autor:
Zhang L; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China., Li Q; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.; Jiangsu Recbio Technology Co., Ltd., Taizhou, People's Republic of China., Liang Z; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.; Graduate School of Peking Union Medical College, Beijing, People's Republic of China., Li T; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China., Liu S; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China., Cui Q; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China., Nie J; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China., Wu Q; Translational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, People's Republic of China., Qu X; Translational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, People's Republic of China., Huang W; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China., Wang Y; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Publikováno v:
Emerging microbes & infections [Emerg Microbes Infect] 2022 Dec; Vol. 11 (1), pp. 1-5.